HomeAI · summaries
Storia in 13 fonti
FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches - Philip Morris Int
FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk claims after scientific review.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA authorizes marketing of risk modification claim on Zyn nicotine pouches
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press…
- ·
morningstar.com
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
